View in EDS

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.

Saved in:
Bibliographic Details
Title: Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.
Authors: Nanda R; The University of Chicago, Chicago, Illinois., Liu MC; Mayo Clinic, Rochester, Minnesota., Yau C; University of California, San Francisco., Shatsky R; University of California, San Diego., Pusztai L; Yale University, New Haven, Connecticut., Wallace A; University of California, San Diego., Chien AJ; University of California, San Francisco., Forero-Torres A; University of Alabama, Birmingham., Ellis E; Swedish Cancer Center., Han H; Moffitt Cancer Center, Tampa, Florida., Clark A; University of Pennsylvania, Philadelphia., Albain K; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Boughey JC; Mayo Clinic, Rochester, Minnesota., Jaskowiak NT; The University of Chicago, Chicago, Illinois., Elias A; University of Colorado, Aurora., Isaacs C; Georgetown University, Washington, DC., Kemmer K; Oregon Health & Science University, Portland., Helsten T; University of California, San Diego., Majure M; University of California, San Francisco., Stringer-Reasor E; University of Alabama, Birmingham., Parker C; The University of Chicago, Chicago, Illinois., Lee MC; Moffitt Cancer Center, Tampa, Florida., Haddad T; Mayo Clinic, Rochester, Minnesota., Cohen RN; The University of Chicago, Chicago, Illinois., Asare S; Quantum Leap Healthcare Collaborative, San Francisco, California., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Hirst GL; University of California, San Francisco., Singhrao R; University of California, San Francisco., Steeg K; University of California, San Francisco., Asare A; Quantum Leap Healthcare Collaborative, San Francisco, California., Matthews JB; University of California, San Francisco., Berry S; Berry Consultants, LLC., Sanil A; Berry Consultants, LLC., Schwab R; University of California, San Diego., Symmans WF; MD Anderson Cancer Center, Houston, Texas., van 't Veer L; University of California, San Francisco., Yee D; University of Minnesota, Minneapolis., DeMichele A; University of Pennsylvania, Philadelphia., Hylton NM; University of California, San Francisco., Melisko M; University of California, San Francisco., Perlmutter J; Gemini Group, Ann Arbor, Michigan., Rugo HS; University of California, San Francisco., Berry DA; Berry Consultants, LLC., Esserman LJ; University of California, San Francisco.
Source: JAMA oncology [JAMA Oncol] 2020 May 01; Vol. 6 (5), pp. 676-684.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Adaptive Clinical Trial
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32053137
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; The University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Shatsky+R%22">Shatsky R</searchLink>; University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Wallace+A%22">Wallace A</searchLink>; University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; University of Alabama, Birmingham.<br /><searchLink fieldCode="AU" term="%22Ellis+E%22">Ellis E</searchLink>; Swedish Cancer Center.<br /><searchLink fieldCode="AU" term="%22Han+H%22">Han H</searchLink>; Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Clark+A%22">Clark A</searchLink>; University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Albain+K%22">Albain K</searchLink>; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Jaskowiak+NT%22">Jaskowiak NT</searchLink>; The University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Elias+A%22">Elias A</searchLink>; University of Colorado, Aurora.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Kemmer+K%22">Kemmer K</searchLink>; Oregon Health & Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Helsten+T%22">Helsten T</searchLink>; University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Majure+M%22">Majure M</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Stringer-Reasor+E%22">Stringer-Reasor E</searchLink>; University of Alabama, Birmingham.<br /><searchLink fieldCode="AU" term="%22Parker+C%22">Parker C</searchLink>; The University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Lee+MC%22">Lee MC</searchLink>; Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Haddad+T%22">Haddad T</searchLink>; Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Cohen+RN%22">Cohen RN</searchLink>; The University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Asare+S%22">Asare S</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Steeg+K%22">Steeg K</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Asare+A%22">Asare A</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Berry+S%22">Berry S</searchLink>; Berry Consultants, LLC.<br /><searchLink fieldCode="AU" term="%22Sanil+A%22">Sanil A</searchLink>; Berry Consultants, LLC.<br /><searchLink fieldCode="AU" term="%22Schwab+R%22">Schwab R</searchLink>; University of California, San Diego.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+L%22">van 't Veer L</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; University of Minnesota, Minneapolis.<br /><searchLink fieldCode="AU" term="%22DeMichele+A%22">DeMichele A</searchLink>; University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Melisko+M%22">Melisko M</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; University of California, San Francisco.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2020 May 01; Vol. 6 (5), pp. 676-684.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Adaptive Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32053137
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2019.6650
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 676
    Titles:
      – TitleFull: Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Shatsky R
      – PersonEntity:
          Name:
            NameFull: Pusztai L
      – PersonEntity:
          Name:
            NameFull: Wallace A
      – PersonEntity:
          Name:
            NameFull: Chien AJ
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Ellis E
      – PersonEntity:
          Name:
            NameFull: Han H
      – PersonEntity:
          Name:
            NameFull: Clark A
      – PersonEntity:
          Name:
            NameFull: Albain K
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Jaskowiak NT
      – PersonEntity:
          Name:
            NameFull: Elias A
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Kemmer K
      – PersonEntity:
          Name:
            NameFull: Helsten T
      – PersonEntity:
          Name:
            NameFull: Majure M
      – PersonEntity:
          Name:
            NameFull: Stringer-Reasor E
      – PersonEntity:
          Name:
            NameFull: Parker C
      – PersonEntity:
          Name:
            NameFull: Lee MC
      – PersonEntity:
          Name:
            NameFull: Haddad T
      – PersonEntity:
          Name:
            NameFull: Cohen RN
      – PersonEntity:
          Name:
            NameFull: Asare S
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Hirst GL
      – PersonEntity:
          Name:
            NameFull: Singhrao R
      – PersonEntity:
          Name:
            NameFull: Steeg K
      – PersonEntity:
          Name:
            NameFull: Asare A
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: Berry S
      – PersonEntity:
          Name:
            NameFull: Sanil A
      – PersonEntity:
          Name:
            NameFull: Schwab R
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: van 't Veer L
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: DeMichele A
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: Melisko M
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Berry DA
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2020 May 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1